Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Oncology Report

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR.15.5.1141PMID 16596176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the management of basal cell carcinoma

  2008cited by this paper
• The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors.

  2005cited by this paper
• Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors

  2005cited by this paper
• Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels

  2005cited by this paper
• Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype.

  2005cited by this paper
• Molecular aetiology and pathogenesis of basal cell carcinoma

  2005cited by this paper
• The SmoA1 Mouse Model Reveals That Notch Signaling Is Critical for the Growth and Survival of Sonic Hedgehog-Induced Medulloblastomas

  2004cited by this paper
• Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.

  2004cited by this paper
• MYCN in neuronal tumours.

  2004cited by this paper
• Transcriptional profiling of the Sonic hedgehog response: A critical role for N-myc in proliferation of neuronal precursors

  2003cited by this paper
• Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors

  2003cited by this paper
• Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.

  2003cited by this paper
• Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma.

  2003cited by this paper
• Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma.

  2003cited by this paper
• Neuroblastoma tumour genetics: clinical and biological aspects.

  2001cited by this paper
• bcl‐2 protein expression in aggressive and non‐aggressive basal cell carcinomas

  2000cited by this paper
• Guidelines for the management of basal cell carcinoma

  1999cited by this paper
• Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck

  1999cited by this paper
• Activating Smoothened mutations in sporadic basal-cell carcinoma

  1998cited by this paper
• Why classify basal cell carcinomas?

  1998cited by this paper
• The molecular basis of nonmelanoma skin cancer: new understanding.

  1997cited by this paper
• Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.

  1997cited by this paper
• Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin.

  1996cited by this paper
• Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome

  1996cited by this paper
• Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours.

  1995cited by this paper
• Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.

  1995cited by this paper
• Aggressive-growth basal cell carcinoma in young adults.

  1991cited by this paper
• Enhanced expression of the N-myc gene in Wilms' tumors.

  1986cited by this paper
• N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas.

  1985cited by this paper
• Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature.

  1984cited by this paper
• Metastatic basal cell carcinoma

  1984cited by this paper
• Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

  1983cited by this paper
• Prediction of aggressive behavior in basal cell carcinoma

  1982cited by this paper

• Immunopathogenesis and Therapeutic Implications in Basal Cell Carcinoma: Current Concepts and Future Directions

  2025influential citation
• GLI2 and FLNB Define Periocular Morphoeic Basal Cell Carcinoma

  2025cites this paper
• Does Basal Cell Carcinoma Arise from a Precursor Lesion?

  2025cites this paper
• MYCN in human development and diseases

  2024cites this paper
• Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease

  2022cites this paper
• Contribution of Microhomology to Genome Instability: Connection between DNA Repair and Replication Stress

  2022cites this paper
• Periocular Pigmented Basal Cell Carcinomas: Clinicopathologic Features and Mutational Profile

  2022cites this paper
• Molecular Landscape of Skin Carcinomas

  2021cites this paper
• Targeting MYCN in Pediatric and Adult Cancers

  2021cites this paper
• MYCN gene polymorphisms and Wilms tumor susceptibility in Chinese children

  2019cites this paper
• Metastatic Basal Cell Carcinoma.

  2019cites this paper
• Metastatic Basal Cell Carcinoma Molecular Ancillary Testing and Reappraisal of Histopathology Within a Rare Entity

  2019cites this paper
• Understanding the Molecular Genetics of Basal Cell Carcinoma

  2017cites this paper
• The MYCN Protein in Health and Disease

  2017cites this paper
• Investigating the role of epigenetics in the regulation of inflammatory skin disease

  2016cites this paper
• Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma

  2016cites this paper
• Analysis of TRIP Expression in Different Types of Skin Tumor

  2015cites this paper
• Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes.

  2015cites this paper
• PI3K-AKT Signaling Is a Downstream Effector of Retinoid Prevention of Murine Basal Cell Carcinogenesis

  2014cites this paper
• The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics.

  2012cites this paper
• Painel imunoistoquímico para distinção entre tricoepitelioma e carcinoma basocelular desenvolvido utilizando a técnica do TMA

  2012cites this paper
• The Role of FGF Signaling During Granule Neuron Precursor Development and Tumorigenesis

  2010cites this paper
• Aktivierung des Sonic-hedgehog-Signalwegs in keratozystischen odontogenen Tumoren

  2009cites this paper
• L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.

  2008cites this paper
• Transcriptional profiling identifies an interferon‐associated host immune response in invasive squamous cell carcinoma of the skin

  2008cites this paper
• Childhood tumors of the nervous system as disorders of normal development

  2006cites this paper